Viewing data from:

LYMPHOSEEK KIT

NDA

TECHNETIUM TC-99M TILMANOCEPT | N202207 | CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES

1 strength1 unique patent0 unique exclusivities

Patent Timeline

1 unique patent by expiration date

Active (1)Today

2027

2028

2029

Today

Jan. 30, 2029

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

5 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — N/A

RLD

1 patent0 exclusivities▴

INJECTABLE;INJECTION | Approved: Mar 13, 2013

Patent #	Expiration	PED	Drug Substance	Drug Product	Use Code	Delist
9439985	Jan 30, 2029	—	—	Yes	—	—